Etiology and pathogenesis of Sjogren's syndrome: an overview

被引:0
|
作者
Vitali, C
Papa, D
机构
[1] Piombino Hosp, Dept Internal Med & Rheumatol, Piombino, Italy
[2] G Pini Hosp, Rheumat Dis Unit, Milan, Italy
关键词
Sjbgren's syndrome; etiopathogenesis; viral infections; T- and B-cells; autoantibodies;
D O I
10.1055/s-2005-857988
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sjogren's syndrome (SS) is a systemic autoimmune disease characterised by lymphocytic infiltrates in exocrine glands, particularly in salivary and lachrymal glands, and in about 20% of patients also in some internal organs, like kidney and lung. The pathogenesis of SS is poorly understood. Genetic and environmental factors appear to have a key role in favouring the disease development. in particular some viral infections have been demonstrated to be able to trigger the disease process. The majority of the infiltrating cells in target organs are CD4 + CD27 + memory cells. Furthermore, a number of B cells are present in the infiltrates and several features of SS are attributed to their presence. The presence of autoantibodies, such as anti-SSA and -SSB is related to the presence of reactive B cell against ubiquitous nuclear antigens, probably released during the apoptotic process of glandular epithelial cells. The presence of specific anti-muscarinic (M3) receptor antibodies may have some importance in reducing the glandular secretion, behind the epithelial damage caused by the chronic inflammatory infiltrates. The continuous T cell-related stimulation and activation of B cells may induce neoplastic transformation and development of lymphomas.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 50 条
  • [31] Evaluation of the oral component of Sjogren's syndrome: An overview
    Aoun, Georges
    Nasseh, Ibrahim
    Berberi, Antoine
    JOURNAL OF INTERNATIONAL SOCIETY OF PREVENTIVE AND COMMUNITY DENTISTRY, 2016, 6 (04): : 278 - 284
  • [32] Endocrine alterations in primary Sjogren's syndrome: An overview
    Mavragani, Clio P.
    Fragoulis, George E.
    Moutsopoulos, Haralampos M.
    JOURNAL OF AUTOIMMUNITY, 2012, 39 (04) : 354 - 358
  • [33] Sjogren's Syndrome: an undiagnosed etiology for facial pain Case series with review of neurological manifestation of Sjogren syndrome
    Borensztejn, Ignacio
    Ansari, Hossein
    Siami-Namini, Koushan
    Newman, Kam A.
    AUTOIMMUNITY REVIEWS, 2021, 20 (03)
  • [34] Usefulness of mouse models to study the pathogenesis of Sjogren's syndrome
    Soyfool, M. S.
    Steinfeld, S.
    Delporte, C.
    ORAL DISEASES, 2007, 13 (04) : 366 - 375
  • [35] B-Lymphocytes Govern the Pathogenesis of Sjogren's Syndrome
    Youinou, Pierre
    Saraux, Alain
    Pers, Jacques-Olivier
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (10) : 2071 - 2077
  • [36] Pathogenesis of primary Sjogren's syndrome beyond B lymphocytes
    Fasano, S.
    Mauro, D.
    Macaluso, F.
    Xiao, F.
    Zhao, Y.
    Lu, L.
    Guggino, G.
    Ciccia, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (04) : S315 - S323
  • [37] Sjogren's syndrome: a review of aetiology, pathogenesis, diagnosis and management
    Bayetto, K.
    Logan, R. M.
    AUSTRALIAN DENTAL JOURNAL, 2010, 55 : 39 - 47
  • [38] Pathogenesis of autoimmune disorders: Lessons from Sjogren's syndrome
    Moutsopoulos, H. M.
    EADV: Proceedings of the 15th Congress of the European Academy of Dermatology and Venereology, 2006, : 195 - 196
  • [39] The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome
    Manoussakis, Menelaos N.
    Kapsogeorgou, Efstathia K.
    JOURNAL OF AUTOIMMUNITY, 2010, 35 (03) : 219 - 224
  • [40] Plasmacytoid dendritic cells promote the pathogenesis of Sjogren's syndrome
    Zhou, Jing
    Zhang, Xiaofeng
    Yu, Qing
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2022, 1868 (02):